These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 11910653

  • 1. The role of megestrol acetate as an alternative to conventional hormone replacement therapy.
    Farish E, Barnes JF, O'Donoghue F, Fletcher CD, Ekevall K, Hart DM.
    Climacteric; 2000 Jun; 3(2):125-34. PubMed ID: 11910653
    [Abstract] [Full Text] [Related]

  • 2. Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma.
    Costa LA, Kopreski MS, Demers LM, Chinchilli VM, Santen RJ, Harvey HA, Lipton A.
    Cancer; 1999 Jan 01; 85(1):100-3. PubMed ID: 9921980
    [Abstract] [Full Text] [Related]

  • 3. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 Jan 01; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol.
    Conard J, Basdevant A, Thomas JL, Ochsenbein E, Denis C, Guyene TT, Degrelle H.
    Fertil Steril; 1995 Nov 01; 64(5):957-62. PubMed ID: 7589641
    [Abstract] [Full Text] [Related]

  • 5. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
    Cachrimanidou AC, Hellberg D, Nilsson S, von Schoulz B, Crona N, Siegbahn A.
    Contraception; 1994 Aug 01; 50(2):153-65. PubMed ID: 7956214
    [Abstract] [Full Text] [Related]

  • 6. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.
    Farish E, Spowart K, Barnes JF, Fletcher CD, Calder A, Brown A, Hart DM.
    Atherosclerosis; 1996 Sep 27; 126(1):77-84. PubMed ID: 8879436
    [Abstract] [Full Text] [Related]

  • 7. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
    Godsland IF.
    Fertil Steril; 2001 May 27; 75(5):898-915. PubMed ID: 11334901
    [Abstract] [Full Text] [Related]

  • 8. Effects of estradiol-drospirenone on menopausal symptoms, lipids and bone turnover in Chinese women.
    Li M, Wang A, Hu L, Song Z, Zhao Y, Sun Y, Yan L, Li X.
    Climacteric; 2015 Apr 27; 18(2):214-8. PubMed ID: 25362969
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hormone replacement therapy and lipid-lipoprotein concentrations.
    Gökmen O, Yapar Eyi EG.
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul 27; 85(1):31-41. PubMed ID: 10428319
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK, Coglan MJ, Wright GR, DeVoss KN, Battistutta D.
    Med J Aust; 1998 Mar 02; 168(5):216-20. PubMed ID: 9539899
    [Abstract] [Full Text] [Related]

  • 14. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
    Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM.
    N Engl J Med; 1991 Oct 24; 325(17):1196-204. PubMed ID: 1922206
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A double-blind randomised controlled trial of the effects of medroxyprogesterone acetate on bone density of women taking oestrogen replacement therapy.
    Adachi JD, Sargeant EJ, Sagle MA, Lamont D, Fawcett PD, Bensen WG, McQueen M, Nazir DJ, Goldsmith CH.
    Br J Obstet Gynaecol; 1997 Jan 24; 104(1):64-70. PubMed ID: 8988699
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T, Creatsas G, Rechberger T, Depypere H, Erenus M, Quail D, Arndt T, Bonnar J, Euralox 1 Study Group.
    Climacteric; 2001 Dec 24; 4(4):320-31. PubMed ID: 11770189
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.